VIRAGEN

Sep 14, 07
	NEW STORY
16:08 ET	Viragen International's Subsidiary, ViraNative AB, Files to Seek Bankruptcy Protection in Sweden
Sep 04, 07
16:00 ET	Viragen International to Reverse Split Its Common Stock
Jul 11, 07
16:45 ET	Viragen to Begin OTC Trading; New Symbols Assigned
Jul 06, 07
16:15 ET	Viragen Announces Amex Delisting
Jun 29, 07
16:15 ET	Viragen International Announces Plan to Optimize Capital Structure
Jun 21, 07
17:30 ET	Viragen Streamlines Research Focus and Halts Further Development of OVA(TM) System
May 24, 07
12:00 ET	Viragen Requests Hearing to Appeal AMEX Notice of Delisting
May 18, 07
17:00 ET	Viragen Receives Delisting Notice from Amex
May 08, 07
06:12 ET	Multiferon(R) Shows Potent Activity in Preventing the Progression of Malignant Melanoma; Study to be Published
May 07, 07
07:00 ET	Viragen Reports Expression Breakthrough Using OVA(TM) System for Therapeutic Protein Production
May 04, 07
16:15 ET	Viragen Shifts Development Focus for Anti-Cancer Products
15:58 ET	Viragen to Present at BIO International Convention
Apr 18, 07
11:30 ET	Viragen Announces European Multiferon(R) Licensing Agreement
Apr 16, 07
07:00 ET	Viragen Completes $3 Million Financing with London Institutional Investor, RAB Capital plc
Mar 20, 07
15:53 ET	Viragen Announces Debt Restructuring; Expects to Demonstrate Amex Compliance
Feb 01, 07
14:52 ET	Viragen to Present at BIO CEO & Investor Conference
Jan 25, 07
12:00 ET	Viragen Provides 2007 Outlook: Part II
Jan 24, 07
14:30 ET	Viragen's CEO Provides Outlook for 2007
Jan 23, 07
10:45 ET	Viragen Reports OVA(TM) System Milestone: Interferon Alpha Expressed in Eggs
Jan 16, 07
09:06 ET	Viragen Announces That OVA(TM) System Results are Published in Leading U.S. Scientific Journal
Dec 28, 06
15:29 ET	Viragen Licenses Exclusive Marketing Rights for Multiferon(R) in Australia and New Zealand
Dec 20, 06
10:48 ET	Dawson James Securities Initiates Research Coverage on Viragen, Inc.
Nov 28, 06
13:09 ET	Viragen and AFG BioSolutions Report Positive Anti-Viral Drug Data
Nov 22, 06
15:50 ET	Viragen Announces Separation of Units
Nov 03, 06
18:34 ET	Viragen Announces Closing of Secondary Unit Offering
17:15 ET	Viragen Announces Closing of Secondary Unit Offering
Oct 31, 06
06:30 ET	Viragen Announces Pricing of Public Offering of Units
Jul 31, 06
12:16 ET	Viragen Files Preliminary Prospectus for Secondary Stock Offering
Jul 28, 06
09:40 ET	Viragen International Completes $1.8 Million Private Placement Financing
Jun 20, 06
09:56 ET	Multiferon(R) Article Published in Leading Cancer Journal; Reports Significant Malignant Melanoma Survival Results
May 31, 06
10:19 ET	Viragen Reports Continued U.S. Army Studies of Multiferon(R); Research Marks Next Step Toward Determining Biodefense Potential
May 22, 06
12:54 ET	Viragen to Highlight Multiferon(R) Treatment Advantages at Melanoma Conference
May 09, 06
10:20 ET	Viragen Announces Research Collaboration With Prominent Biodefense Consultant to U.S.
Mar 27, 06
10:41 ET	Multiferon(R) Melanoma Article Accepted for Publication in Leading Cancer Journal
Mar 21, 06
17:19 ET	Viragen Completes $5.2 Million Financing
Mar 13, 06
18:05 ET	Viragen Announces Financing Strategy
Mar 03, 06
16:30 ET	Viragen Reports on Amex Compliance Plan
Feb 28, 06
09:50 ET	Viragen to Present Multiferon(R) European Strategy at BioSquare 2006
Feb 21, 06
02:00 ET	Viragen's Multiferon(R) Approved in Sweden for First-Line Adjuvant Treatment of Malignant Melanoma
Feb 07, 06
09:15 ET	Viragen Reports on Multiferon(R) Anti-Viral Studies with U.S. Army Researchers
Jan 19, 06
10:39 ET	Viragen Announces Investment Banking Agreement With Janney Montgomery Scott
Jan 18, 06
11:00 ET	Viragen Reports Avian Transgenic Breakthrough: OVA(TM) System Expresses Interferon-Beta
Dec 20, 05
13:57 ET	Viragen Reports Annual Meeting Voting Results
Dec 15, 05
07:30 ET	Viragen Holds Annual Stockholder Meeting: CEO Issues Progress Report
Dec 06, 05
10:54 ET	Viragen Announces Asian Expansion With South Korean Multiferon(R) Marketing Agreement
Nov 21, 05
06:00 ET	Viragen Comments on Avian Flu Results
Nov 18, 05
14:24 ET	Viragen Reports Results from Preliminary Avian Flu Studies
Nov 02, 05
12:53 ET	Viragen to Present at BIO-Europe 2005
Nov 01, 05
10:36 ET	Viragen and Roslin Institute Renew Agreement to Produce Human Drugs in Transgenic Hens' Eggs
Oct 31, 05
11:17 ET	Amex Approves Viragen's Compliance Plan and Grants Trading Extension Into 2007
Oct 03, 05
10:44 ET	Viragen Names Karen Jervis Vice President and Managing Director of Viragen Scotland
Sep 22, 05
16:13 ET	Viragen to Submit Compliance Plan to Amex
Sep 15, 05
16:43 ET	Viragen Restructures Debt with New Financing Agreements
Sep 13, 05
17:42 ET	Viragen Issues Annual Report
Aug 31, 05
07:00 ET	Viragen to Present Multiferon(R) Trial Results at World Congress on Melanoma
Jun 27, 05
07:00 ET	UK Investment Firm, Williams de Broe, Reiterates Buy Recommendation on Viragen
Jun 20, 05
07:00 ET	Viragen's Multiferon(R) Approved for Sale in Chile
Jun 16, 05
14:17 ET	Multimedia News Release -- Viragen Reports Achievement of Key Avian Transgenics Milestone
10:19 ET	Viragen to Present at BIO 2005
May 18, 05
16:30 ET	Viragen Reports Peptide Agreement Expired
May 09, 05
10:31 ET	Viragen Licenses 'Anti-CD55 Antibody' Cancer Therapy from Cancer Research Technology
Apr 25, 05
07:01 ET	Viragen's Multiferon(R) Approved for Sale in the Philippines
Apr 18, 05
08:58 ET	Viragen to Present Data on Multiferon(R) Trial Results at 2005 ASCO Annual Meeting
Apr 14, 05
07:01 ET	Viragen to Present at Rodman & Renshaw 2nd Annual Global Healthcare Conference
Mar 17, 05
09:09 ET	Viragen Antibody Enhances Effect of Leading Cancer Drug
Feb 17, 05
10:01 ET	Viragen Reports Advancement in Avian Transgenics Biomanufacturing
Feb 10, 05
07:00 ET	Viragen Announces Agenda for Annual Meeting of Stockholders
Feb 07, 05
11:14 ET	Viragen Appoints Dartmouth Cancer Research Scientist to Board of Directors
Feb 04, 05
10:37 ET	Viragen Files to Expand Cancer Approval for Multiferon(R) in Sweden
Jan 12, 05
07:00 ET	Viragen CEO Provides Business Update and Outlook for 2005
Nov 22, 04
10:36 ET	Viragen's Multiferon(R) Approved for Sale in Bulgaria
Nov 02, 04
10:08 ET	Viragen to Present on Biotechnology Webcast
Oct 28, 04
07:00 ET	Viragen to Present at 'BIO-Europe 2004'
Oct 14, 04
11:55 ET	Viragen Reports Increased Demand for Multiferon in Mexico
Oct 11, 04
10:52 ET	Viragen to Present at BIO Event
Oct 07, 04
13:26 ET	Viragen Reports Williams de Broe Increases Sales Forecasts for Multiferon(R) Based on Cancer Study
Oct 05, 04
09:15 ET	Viragen's Multiferon(R) Demonstrates Statistically Significant Increase in Overall Survival in Melanoma Study
Sep 13, 04
07:00 ET	UK Investment Firm, Williams de Broe, Initiates Research Coverage on Viragen
Aug 26, 04
09:45 ET	Viragen Scheduled To Appear on 'BioTech Today' Radio Program
Aug 19, 04
07:59 ET	Viragen Issues Progress Report
Jul 29, 04
10:43 ET	Viragen Granted U.S. Patent for Manufacture of Multiferon(TM)
Jul 22, 04
10:10 ET	Viragen Reports on Plans to Produce Multiferon(TM) at New Swedish Manufacturing Facility
Jul 06, 04
05:59 ET	Viragen Licenses Oxford BioMedica's LentiVector(R) Gene Delivery System for Use in Avian Transgenics Biomanufacturing Program
Jun 29, 04
10:57 ET	Viragen Completes $20 Million Financing
Jun 21, 04
08:03 ET	Viragen Publication Alert:
Jun 15, 04
09:00 ET	Multiferon(TM) Update: Medical Journal Reports Successful Use of Viragen's Natural Interferon for Treatment of Hepatitis C
Jun 14, 04
07:00 ET	Viragen's Stockholders Approve to Complete $20 Million Financing
Jun 02, 04
09:31 ET	Viragen to Present at New York Biotech Forum
May 25, 04
06:59 ET	Viragen's CEO, Charles A. Rice, Outlines Growth Strategy to Stockholders
May 13, 04
08:30 ET	Shelf-Life for Multiferon Extended as Viragen Advances Marketing Campaign
May 12, 04
09:30 ET	Viragen and University of Miami to Advance Anti-Cancer Study
Apr 28, 04
09:15 ET	Viragen Added to PCE Florida Stock Index
Apr 15, 04
09:52 ET	Scotland Awards Grant to Viragen for Cancer Research
Apr 05, 04
07:01 ET	Viragen Announces $20 Million Financing Agreement
Mar 30, 04
10:03 ET	Viragen Announces New Partnerships to Develop Electroporation Technology for Avian Transgenic Biomanufacturing
Mar 23, 04
08:32 ET	Viragen To Present At Biotech Event
Mar 11, 04
09:58 ET	Viragen Names New President and CEO
Mar 10, 04
09:02 ET	Viragen Files U.S. Patent Application For Natural Interferon To Target SARS
Mar 08, 04
10:47 ET	Viragen and Roslin Institute Announce Extended Agreement
Feb 18, 04
09:15 ET	Viragen Launches Multiferon Sales And Marketing Program In Mexico
Jan 21, 04
07:01 ET	Viragen To Present At Chinese Business Forum
Jan 13, 04
10:50 ET	Viragen To Present At Friedland Capital Event
Dec 30, 03
11:33 ET	Viragen Announces New Round Of Equity Financing
Dec 04, 03
15:34 ET	Viragen Strengthens Board and Achieves Majority of Independent Directors
Dec 03, 03
07:45 ET	Webcast Alert: Viragen, Inc. (VRA) Announces Presentation At The American Stock Exchange Online Conference
Dec 01, 03
07:45 ET	Webcast Alert: Viragen, Inc. (VRA) Announces Presentation At The American Stock Exchange Online Conference
Nov 25, 03
10:51 ET	Viragen To Present On Amex Webcast
Nov 17, 03
08:32 ET	Viragen Signs Agreement with South American Subsidiary of Fresenius Medical Care
Oct 31, 03
12:45 ET	Viragen Moves Toward Independent Board
Oct 07, 03
12:32 ET	Viragen Strengthens Cash Position To Provide Working Capital For Better Than One Year
Sep 18, 03
08:29 ET	Viragen Featured In Biomanufacturing Report
Sep 04, 03
08:59 ET	Viragen Drug Proves Effective Against SARS In Research Study
Sep 02, 03
12:00 ET	Viragen To Present On Biotech Webcast
Aug 11, 03
07:00 ET	Viragen Interview Discusses Project to Manufacture Drugs in Chicken Eggs
Aug 04, 03
08:02 ET	Viragen To Appear On 'Biotech Today'
Jul 23, 03
10:30 ET	Viragen Comments on Interferon Study Which Demonstrates Anti-Cancer Activity
Jul 01, 03
07:01 ET	Viragen Completes $5.5 Million Debt Financing
Jun 25, 03
07:02 ET	Viragen Strengthens Board
Jun 18, 03
09:30 ET	Viragen's Chairman Presents Mid-Year Progress Report
May 30, 03
13:27 ET	Viragen Continues To Meet American Stock Exchange Listing Criteria
May 29, 03
08:59 ET	Mexico Expands Approval For Viragen's Natural Interferon
May 27, 03
10:24 ET	Viragen Expands Drug Distribution Network
May 22, 03
08:29 ET	Viragen Signs Drug Distribution Agreement for Hong Kong
May 20, 03
10:31 ET	Viragen Files Patent Application For Drug To Target SARS
May 06, 03
13:03 ET	Viragen Featured In 'Science Magazine'
Apr 30, 03
08:45 ET	Viragen Obtains Debt Financing
Apr 01, 03
07:02 ET	Viragen Announces $12 Million Financing Agreement
Mar 18, 03
02:00 ET	Viragen Enters into Transgenics Agreement with Oxford BioMedica
Mar 10, 03
07:00 ET	South Africa Approves Viragen's Natural Interferon
Mar 04, 03
07:00 ET	Viragen Announces Major Restructuring Plan
Feb 28, 03
07:00 ET	ViraGenics Names Former Chief of Roslin Institute as Director
Feb 12, 03
07:01 ET	Viragen Reports New Initiatives
Jan 31, 03
07:00 ET	Viragen Extends Agreement with Mexico Drug Distributor
Jan 30, 03
07:02 ET	Viragen Appoints Carl N. Singer Chairman and Robert C. Salisbury Chief Executive Officer
07:02 ET	Viragen International Appoints Carl N. Singer Chairman, President and CEO
Jan 29, 03
09:30 ET	Viragen Announces Initial Multiferon Shipment to Taiwan
Jan 22, 03
07:01 ET	Viragen Targets China As Part Of Drug Marketing Strategy
Jan 14, 03
07:00 ET	Viragen's CEO Responds to Frequently Asked Questions
Dec 17, 02
07:00 ET	Viragen's CEO Provides Year-end Review
Oct 22, 02
07:00 ET	Viragen Launches South American Sales Program
Sep 25, 02
08:00 ET	Viragen's CEO Provides Progress Report
Sep 20, 02
07:00 ET	Viragen Reports Financing Continues; All Projects Progress
Jul 30, 02
07:00 ET	Viragen And University Of Miami Form Anti-Cancer Project
Jul 16, 02
07:03 ET	Viragen and Roslin Announce Resolution of AviGenics Litigation
Jun 17, 02
07:00 ET	Viragen Announces Key Executive Appointment
May 16, 02
08:32 ET	Viragen Reports Interferon Sales
May 09, 02
07:02 ET	Viragen Reports on Natural Interferon Marketing Strategy
Apr 18, 02
07:08 ET	Viragen Announces New Financing
Apr 03, 02
07:00 ET	Viragen Announces Interferon Sales Agreements
Mar 27, 02
08:10 ET	Viragen International To Trade Under New Symbol
Mar 20, 02
07:02 ET	Viragen Reports Melanoma Trial Results
Mar 19, 02
06:59 ET	Viragen Granted Interferon Patent
Mar 12, 02
07:02 ET	Viragen Reports to Stockholders
Feb 28, 02
07:00 ET	Viragen to Present Melanoma Trial Results
Feb 05, 02
07:01 ET	Viragen's CEO Sets Milestones; To Present at BIO Industry Conference
Jan 31, 02
07:00 ET	Mexico Approves Viragen's Natural Interferon
Jan 22, 02
07:02 ET	Viragen's CEO Answers Frequently Asked Questions
Jan 17, 02
07:06 ET	Viragen Receives Important Regulatory Approval
Jan 16, 02
13:15 ET	Viragen Announces Arrangement Of $2.5 Million Financing
Nov 28, 01
07:01 ET	Viragen's CEO Reports On Interferon Strategy
Nov 13, 01
07:03 ET	Viragen Presents at BioNorth 2001
Oct 31, 01
07:58 ET	Viragen Signs Quarter Billion Dollar Contract
Oct 11, 01
07:02 ET	Viragen's CEO Details New Strategies
Oct 08, 01
11:12 ET	Viragen Reports on Avian Transgenic Project
Oct 03, 01
07:01 ET	Viragen Confirms Potential Of Avian Transgenics
Oct 01, 01
07:01 ET	Viragen Acquires BioNative
Sep 20, 01
06:59 ET	Viragen's CEO Issues Shareholder Report
Jul 26, 01
06:59 ET	Viragen Reports On Stock Market Investigations
Jul 12, 01
07:01 ET	Viragen and BioNative Sign Letter of Intent
Jun 26, 01
06:59 ET	Viragen Reports On Cancer Vaccine Project
Jun 21, 01
10:15 ET	Viragen Approved To Start MS Clinical Trials
Jun 11, 01
07:01 ET	Viragen to Present at Amex Online Conference
Jun 07, 01
07:01 ET	Viragen and NIH Initiate Pre-Clinical Cancer Studies
May 31, 01
07:01 ET	Viragen Licenses Antibody Humanization Technology From U.K.'s Medical Research Council
Apr 26, 01
12:48 ET	Viragen's CEO Updates Shareholders
07:05 ET	Viragen's CEO Updates Shareholder
Mar 26, 01
07:02 ET	Viragen Conference Call Available for Replay
Mar 22, 01
07:02 ET	Viragen Board Elects Two New Directors
Mar 16, 01
07:02 ET	Viragen Schedules Conference Call; Web Cast To Update Corporate Developments
Mar 13, 01
07:02 ET	Viragen Files Lawsuit Citing Malicious Prosecution And Civil Conspiracy
Mar 05, 01
09:44 ET	Viragen Commences Legal Action Citing Illegal Use Of Internet Message Boards
Feb 28, 01
07:01 ET	Viragen Stockholders Meeting Features Collaboration With Institute That Created 'Dolly The Sheep'
Jan 31, 01
07:02 ET	Pall And Viragen Sign Agreement To Recover White Blood Cells From Blood Filters; Discarded Leukocytes Are Potential Source For Treating Hepatitis C
Dec 20, 00
07:00 ET	Viragen Holds Pre-IND Meeting With FDA
Dec 18, 00
07:01 ET	Viragen Advances into Stage Two of Its Phase II Clinical Trial
Dec 11, 00
09:59 ET	Viragen And Roslin Institute To Hold Press Reception At British Consulate
Dec 05, 00
10:01 ET	Viragen Announces Press Conference
Oct 26, 00
09:23 ET	Viragen Builds Arsenal Against Cancer
Oct 17, 00
07:04 ET	Viragen and Memorial Sloan-Kettering Start Cancer Study
Oct 05, 00
07:01 ET	Viragen Updates Progress; 'E' Newsletter Released On Web Site
Sep 27, 00
07:01 ET	NIH Grants Viragen Exclusive Rights To New Cancer Therapy
Sep 19, 00
06:59 ET	Viragen and Valentis to Develop PEGylated Natural Alpha Interferon To Treat Hepatitis C
Sep 07, 00
07:01 ET	Viragen Granted Worldwide License For New Cancer Vaccine
Sep 06, 00
10:31 ET	Viragen CEO Interviewed by CEOcast.com
Aug 30, 00
09:33 ET	Viragen Files Lawsuit Against Pershing A Division of Donaldson, Lufkin & Jenrette
Aug 29, 00
07:02 ET	Viragen and Zonagen To Study Genital Herpes Treatment
Aug 23, 00
07:02 ET	Viragen's Cancer Vaccine Project Updated; Acclaimed Scientist Presents At Amex Shareholder Meeting
Aug 10, 00
07:01 ET	Viragen Reports on Phase II Clinical Trials; FDA Filing Scheduled
Aug 07, 00
07:00 ET	Viragen Announces Publication Of Its International Patent Application
Jul 27, 00
08:07 ET	Viragen and the U.K.'s Cancer Research Campaign Collaborate To Develop a Cancer Vaccine
Jul 17, 00
08:59 ET	Viragen Named To dbusiness.com 'Top 50 To Watch' List
Jun 22, 00
19:19 ET	Viragen Corrects False Information Disseminated By Third Party
Jun 13, 00
06:59 ET	NASA and Viragen Sign Space Act Agreement
Jun 02, 00
07:01 ET	Viragen's Annual Stockholder Meeting Set; Analyst Report Released, Shares Listed on Berlin Stock Exchange
Apr 17, 00
12:06 ET	Viragen Shares Trade on AMEX
Apr 14, 00
12:04 ET	Viragen To Open Amex On Monday
Apr 13, 00
07:02 ET	Viragen Moves to AMEX
Mar 21, 00
17:50 ET	Viragen And Biosyntech Collaborate On New Interferon Delivery System
Mar 14, 00
17:47 ET	Viragen Registers for $60 Million Financing
Mar 10, 00
17:44 ET	Viragen Chairman Interviewed by Wall Street Reporter.com And Wall Street Transcript.com
Mar 01, 00
17:48 ET	Viragen and CryoLife Sign Collaborative Agreement
Feb 01, 00
16:29 ET	President's Letter
Jan 27, 00
16:00 ET	Viragen Appoints New Directors To European Subsidiary
Dec 29, 99
17:46 ET	Viragen Announces $30 Million Financing By Ladenburg Thalmann
Dec 06, 99
17:45 ET	Memorial Sloan-Kettering Cancer Center And Viragen Sign Collaborative Agreement
11:09 ET	Memorial Sloan-Kettering Cancer Center And Viragen Sign Collaborative Agreement
Oct 08, 99
11:05 ET	Viragen Third Quarter Update